- 501. Days of the week
- (UMLS (HL7) C0585023) =Temporal Concept =HL7 Vocabulary Version 2.5;
=Monday;
Sunday;
Tuesday;
Wednesday;
Thursday;
Friday;
Saturday | - 551. DDTC
- [A chelating agent that has been used to mobilize toxic metals from the tissues of man and experimental animals. It is the main metabolite of DISULFIRAM. ( MSH )] (UMLS (NCI) C0012194) =Organic Chemical; Pharmacologic Substance ;
=thiocarbamate;
=Bis(diethylthiocarbamoyl) Disulfide;
|
- 502. Daytime
- (UMLS (NCI) C0332169) =Temporal Concept
| - 552. DDVP
- [An organophosphorus insecticide that inhibits acetylcholinesterase. ( MSH )] (UMLS (CSP) C0012087) =Organophosphorus Compound; Hazardous or Poisonous Substance
|
- 503. DB-67
- (UMLS (NCI) C0961890) Silatecan DB-67 =Organic Chemical; Pharmacologic Substance
| - 553. DDVP (dichlorodimethylvinylphosphate)
- [ ] (UMLS (CSP) C0598155) =Organic Chemical; Hazardous or Poisonous Substance
|
- 504. DBA
- (UMLS (NCI) C0025923) =Mammal ;
| - 554. DDX1
- [This gene plays a role in the regulation of several processes involving the alteration of RNA secondary structure. ( NCI )] (UMLS (NCI) C1333209) DDX1 Gene;
DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 1 Gene =Gene or Genome ;
|
- 505. DBC1
- [Encoded by human tumor suppressor DBCCR1 Gene, 761-amino acid 88.9-kD DBCCR1 Protein contains a MAC/Perforin domain, seven potential N-glycosylation sites, four N-myristoylation sites, and thirty phosphorylation sites. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0675026) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 555. DDX16
- [This gene plays a role in RNA splicing. ( NCI )] (UMLS (NCI) C1333208) DDX16 Gene;
DEAH (Asp-Glu-Ala-His) Box Polypeptide 16 Gene =Gene or Genome ;
|
- 506. DBC1
- [This gene plays a role in receptor-mediated signal transduction. ( NCI )] (UMLS (NCI) C1413915) DBC1 Gene;
Deleted in Bladder Cancer 1 Gene =Gene or Genome | - 556. DDX26
- [Encoded by human DDX26 Gene (DEAD Family), the highly conserved candidate tumor suppressor 1687-amino acid 188.5-kD DEAD/H Box Protein 26 contains a vWF type A domain. With a likely important cellular function, DDX26 is expressed in a variety of fetal and adult tissues. DEAD box proteins, characterized by a conserved Asp-Glu-Ala-Asp (DEAD) motif, are putative RNA helicases that alter RNA secondary structure and influence translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. Based on distribution, some family members may be involved in embryogenesis, spermatogenesis, and cellular growth and division. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0909050) DDX26 Protein;
DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 26;
DEAD/H BOX 26;
DEAD/H Box Protein 26;
EGF Repeat Transmembrane Protein;
RNA Helicase HDB;
RNA Helicase HDB/DICE1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 507. DBD/5-FU/MTX/PRED
- (UMLS (NCI) C0279356) =Therapeutic or Preventive Procedure
| - 557. DDX26
- [This gene may play a role in the transcriptional regulation that modulates chondrogenesis. ( NCI )] (UMLS (NCI) C1333210) DDX26 Gene;
DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 26 Gene =Gene or Genome ;
|
- 508. DBD/DOX
- (UMLS (NCI) C0278921) =Therapeutic or Preventive Procedure
| - 558. DDX6
- [A putative RNA helicase ( NCI )] (UMLS (NCI) C0674363) =Amino Acid, Peptide, or Protein; Enzyme
|
- 509. DBF4
- [This gene is involved in DNA replication, protein binding and cell cycle control. ( NCI )] (UMLS (NCI) C1332118) DBF4 Gene;
DBF4 Homolog (S. cerevisiae) wt Allele =Gene or Genome ;
| - 559. DDX6
- [This gene plays a role in the translation of mRNA encoded by genes involved in cell proliferation and malignant transformation. ( NCI )] (UMLS (NCI) C0812257) DDX6 Gene;
DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 6 Gene =Gene or Genome |
- 510. DBH (dopamine beta hydroxylase)
- [ ] (UMLS (CSP) C0013032) =Amino Acid, Peptide, or Protein; Enzyme ;
=Oxygenase;
| - 560. DE
- [A state in the mid-atlantic United States. Its capital is Dover. ( NCI )] (UMLS (NCI) C0011198) =Geographic Area ;
◊ [central European country bordering on the North and Baltic Seas, capital Berlin. ( CSP )] (UMLS (NCI) C0017480) Geographic Area ; Europe; |
- 511. DBL
- [This gene is involved in signal transduction. ( NCI )] (UMLS (NCI) C0812211) Diffuse B-Cell Lymphoma Oncogene;
MCF.2 Cell Line Derived Transforming Sequence;
MCF2;
MCF2 Cell Line Derived Transforming Sequence Gene;
MCF2 Gene;
Oncogene DBL;
Oncogene MCF2;
Oncogene, DBL;
Oncogene, MCF-2 =Gene or Genome | - 561. De Galantha stain
- [Stain, De Galantha ( HL7V3.0 )] (UMLS (HL7) C1293969) =Laboratory Procedure =ObservationMethod;
|
- 512. DBL Oncoprotein
- [Human DBL Oncoprotein is product of a mutated variant (Oncogene DBL) of widely expressed MCF2 Gene, which encodes 4 alternative variants of 66-kDa MCF2 (DBL) p66 Protein, a cytoplasmic and membrane phosphoserine guanine nucleotide exchange factor that modulates the activity of small RHO GTPases by promoting conversion from GDP- to GTP-bound form. p66 contains a CRAL-TRIO domain, a DH domain, a PH domain and a spectrin repeat; the DH domain catalyzes GDP-GTP exchange. Activated DBL oncogene is generated by 5-prime recombination with 3 (pter-p21) and by 3-prime recombination with 16 (p13-q22). The truncated DBL oncogene is active toward RHOA, RAC1 and CDC42. DBL Oncoprotein disrupts normal cell function. ( NCI )] (UMLS (NCI) C0069500) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 562. De novo Acute Myeloid Leukemia with Multilineage Dysplasia
- (UMLS (NCI) C1333259) =Neoplastic Process ;
|
- 513. DBS
- [A highly invasive form of electroanalgesia mainly used in the management of debilitating chronic pain syndromes after all other less invasive therapeutic modalities (including SCS) have failed. (White, Li, and Chiu) ( NCI )] (UMLS (NCI) C0394162) =Therapeutic or Preventive Procedure
| - 563. de novo Myelodysplastic Syndrome
- (UMLS (NCI) C0280451) =Neoplastic Process
|
- 514. DC 13116
- (UMLS (NCI) C0245668) =Amino Acid, Peptide, or Protein
| - 564. De Quervain's Thyroiditis
- (UMLS (NCI) C0342176) =Disease or Syndrome ;
|
- 515. DC-Chol Liposomes
- [A cationic cholesterol derivative mixed with dimethylaminoethane-carbamoyl and sonicated to form small unilamellar vesicles that can complex with DNA, DNA/protein complexes and other drug complexes and mediates the delivery into the cytosol from the endosome compartment. (NCI) ( NCI )] (UMLS (NCI) C0935779) DC-Cholesterol Liposome;
Dimethylaminoethane-carbamoyl-cholesterol Liposomes =Lipid; Pharmacologic Substance | - 565. De Toni-Debre-Fanconi Syndrome
- [constellation of clinical and laboratory manifestations produced by generalized proximal tubular insufficiency in the presence of normal, or nearly normal, glomerular filtration. ( CSP )] (UMLS (NCI) C0015624) =Disease or Syndrome =cystine storage disease;
syndrome;
inborn biological transport disorder;
|
- 516. DC-Chol Liposomes/EGFR Antisense DNA
- (UMLS (NCI) C0935780) =Therapeutic or Preventive Procedure ;
| - 566. Deacetylase
- [An enzyme that hydrolyzes N-acetyl groups. ( NCI )] (UMLS (NCI) C1333261) =Amino Acid, Peptide, or Protein; Enzyme
|
- 517. DCC
- [This gene plays a role in the regulation of several processes involving the alteration of RNA secondary structure. ( NCI )] (UMLS (NCI) C0079414) =Gene or Genome ;
| - 567. Deactivate: discontinue using record in master file, but do not delete from database
- (UMLS (HL7) C1549607) =Intellectual Product =Record-level event code;
|
- 518. DCF/FAMP
- (UMLS (NCI) C0279044) =Therapeutic or Preventive Procedure
| - 568. deacylation
- [ ] (UMLS (CSP) C0597762) =Natural Phenomenon or Process ;
|
- 519. DCF/GM-CSF
- (UMLS (NCI) C0281021) =Therapeutic or Preventive Procedure
| - 569. Dead on Arrival (DOA)
- (UMLS (HL7) C1547232) =Intellectual Product =Triage Code;
|
- 520. DCF/IFF/IFN-A
- (UMLS (NCI) C0338179) =Therapeutic or Preventive Procedure
| - 570. DEADrugSchedule
- [DEA schedule for a drug. ( HL7V3.0 )] (UMLS (HL7) C1697989) =Intellectual Product =Controlled Substance;
|
- 521. DCF/MP/MTX
- (UMLS (NCI) C0278933) =Therapeutic or Preventive Procedure
| - 571. DEAE (diethylaminoethyl) resin for transfection
- [ ] (UMLS (CSP) C0599564) =Indicator, Reagent, or Diagnostic Aid ;
|
- 522. DCIS and ILC
- (UMLS (NCI) C0334384) =Neoplastic Process
| - 572. DEAE chromatography
- [ ] (UMLS (CSP) C0598730) =Laboratory Procedure ;
|
- 523. DCIS and LCIS of Breast
- [The co-existence of ductal and lobular carcinoma in situ in the breast, without evidence of stromal invasion. ( NCI )] (UMLS (NCI) C0334383) =Neoplastic Process
| - 573. Deaf
- (UMLS (HL7) C1547302) =Intellectual Product =Precaution Code;
|
- 524. DCIS Grade 1
- (UMLS (NCI) C1334413) DIN 1C;
Ductal Intraepithelial Neoplasia, Grade 1C;
Low Grade Ductal Breast Carcinoma In Situ;
Low-Grade DCIS;
Low-Grade Ductal Carcinoma In Situ of Breast =Neoplastic Process | - 574. deaf aid
- [physical or electronic technology for assisting the deaf or hard-of-hearing. ( CSP )] (UMLS (CSP) C0542459) =Medical Device ;
=communication disorder aid;
=lipreading;
sign language;
electrotactile communication;
speech viewer;
|
- 525. DCIS Grade 2
- (UMLS (NCI) C1334206) DIN 2;
Ductal Intraepithelial Neoplasia, Grade 2;
Intermediate Grade Ductal Breast Carcinoma In Situ;
Intermediate-Grade DCIS;
Intermediate-Grade Ductal Carcinoma In Situ of Breast =Neoplastic Process; ;
| - 575. deaf mutism
- [ ] (UMLS (CSP) C0011052) =Disease or Syndrome ;
|
- 526. DCK
- [This gene is involved in deoxyribonucleoside phosphorylation. ( NCI )] (UMLS (NCI) C1333205) DCK Gene;
Deoxycytidine Kinase Gene =Gene or Genome ;
| - 576. Deaf nonspeaking, not elsewhere classifiable
- [ ] (UMLS (ICD9CM) C1955777) DEAF, NONSPEAKING NEC;
=Disease or Syndrome |
- 527. DCM
- [disease of unknown cause characterized by dilation and impaired function of one or both heart ventricles. ( CSP )] (UMLS (CSP) C0264793) =Disease or Syndrome ;
=cardiomyopathy;
| - 577. Deafness all degrees NOS
- [lack or significant deficiency of the sense of hearing.(CSP)] (UMLS (ICPC) C0011053) (Deafness all degrees NOS; GORTASUNA ZATIZKOA EDO OSOA BIKG; Dovhed alle former/grader IKA; Doofheid alle graden NAO; KUUROUS, KAIKKI ASTEET NUD; Surdite tous degres NP; Taubheit/starke Schwerhoerigkeit NNB; xershut shlema o xelkit; minden fajta n.m. suketseg,; Tutti i gradi di sordita NSA; DOVHET/NEDSATT HORSEL IKA; Surdez todos os graus NE; Sordera parcial/completa NC; DOVHET ALLA GRADER UNS) deafness =Disease or Syndrome ;
=auris; hearing disorder; Diagnosis/Diseases Component; =congenital deafness; noise induced deafness; Central Hearing Loss; Deafness, Sudden |
- 528. DCM
- [chlorinated hydrocarbon that has been used as an inhalation anesthetic and acts as a narcotic in high concentrations; its primary use is as a solvent in manufacturing and food technology. ( CSP )] (UMLS (NCI) C0025748) =Organic Chemical; Pharmacologic Substance ;
=chlorohydrocarbon;
haloalkane;
Inactive Ingredient Preparations;
| - 578. dealkylation
- [The removing of alkyl groups from a compound. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) ( MSH )] (UMLS (CSP) C0011059) =Natural Phenomenon or Process ;
|
- 529. dCMP aminohydrolase
- [An enzyme that catalyzes the hydrolytic deamination of deoxycytidylic acid to deoxyuridylic acid and ammonia. It plays an important role in the regulation of the pool of deoxynucleotides in higher organisms. The enzyme also acts on some 5-substituted deoxycytidylic acids. EC 3.5.4.12. ( MSH )] (UMLS (CSP) C0011491) =Amino Acid, Peptide, or Protein; Enzyme ;
=aminohydrolase;
| - 579. deamidation
- [ ] (UMLS (CSP) C1330964) =Natural Phenomenon or Process ;
|
- 530. dCMP Deaminase Gene
- [This gene plays a role in pyrimidine nucleotide metabolism. ( NCI )] (UMLS (NCI) C1413934) DCTD;
DCTD Gene =Gene or Genome | - 580. deaminase
- [ ] (UMLS (CSP) C0582118) =Amino Acid, Peptide, or Protein; Enzyme
|
- 531. DCNU (dichlorethylnitrosourea)
- [ ] (UMLS (CSP) C0598975) =Organic Chemical; Pharmacologic Substance
| - 581. deamination
- [The removal of an amino group (NH2) from a chemical compound. ( MSH )] (UMLS (CSP) C0011061) =Natural Phenomenon or Process ;
|
- 532. Dcr-1 Homolog
- [Endoribonuclease Dicer, encoded by the human DICER1 gene, possesses an RNA helicase motif, containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. It is required by the RNA interference in cleaving double-stranded RNA as well as small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. The 21 to 23 bp double-stranded RNAs (siRNAs) generated target the selective destruction of homologous RNAs. (From OMIM, Swiss-Port, and NCI) ( NCI )] (UMLS (NCI) C1309483) Dicer;
DICER1;
DICER1 Protein;
EC 3.1.26.-;
Endoribonuclease Dicer;
Helicase with RNase Motif;
Helicase-MOI;
HERNA;
Homolog of Drosophila Dicer;
K12H4.8-Like;
KIAA0928 =Amino Acid, Peptide, or Protein; Enzyme ;
| - 582. Death
- (UMLS (HL7) C1546949) =Idea or Concept =Event Consequence;
|
- 533. DCR3
- [Expressed in stomach, spinal cord, lymph node, trachea, spleen, colon and lung, human TNFRSF6B Gene (TNFR Family) encodes isoforms of 300-aa 33-kDa (precursor) secreted Decoy Receptor for FAS Ligand, a decoy receptor containing 4 TNFR-Cys repeats that protects against apoptosis by competing with death receptors for cytotoxic ligands TNFS14 and FasL. (NCI) ( NCI )] (UMLS (NCI) C1259595) Decoy Receptor 3;
Decoy Receptor for FAS Ligand;
M68;
TNFRSF6B;
TR6 =Amino Acid, Peptide, or Protein; Receptor ;
| - 583. Death
- [cessation of life; permanent cessation of all vital bodily functions.(CSP)] (UMLS (ICPC) C0011065) (Death; HERIOTZA (ESKL.PERINATALA); Dod (ex perinatal); Dood/overlijden (ex perinataal); KUOLEMA (EI PERINATAALINEN); Mort (SF perinatale); Tod (ex perinatal); mavet; exitus (kiv. perinatalis); Morte(escl perinatale); DOD/DODSFALL EKS A95; Morte (excl perinatal) ; Fallecimiento (ex perinatal); DOD (EXKL PERINATAL)) Dead =Organism Function ;
=life cycle; Pathologic Process; GENERAL AND UNSPECIFIED; Diagnosis/Diseases Component =autopsy; ASPHYXIA; brain death; cadaver; Death, Sudden; Drowning; Death, Intrauterine Fetal; Embryo Loss |
- 534. DCVax-Lung
- [A cancer vaccine consisting of lymphocytes harvested from a patient with lung cancer and induced to become antigen-presenting cells (APCs) known as dendritic cells. The dendritic cells are transduced with the gene encoding an antigen specific to the patient's cancer and then returned to the patient. In the host, the altered cells stimulate the immune system to mount a primary T cell response against lung tumor cells expressing the target antigen. Dendritic cell-autologous lung tumor vaccines have been investigated for use in cancer immunotherapy. (NCI04) ( NCI )] (UMLS (NCI) C1327750) Dendritic Cell-Autologous Lung Tumor Vaccine;
=Pharmacologic Substance; Immunologic Factor | - 584. Death Adverse Event Not Associated with More Specific CTCAE Term NOS
- (UMLS (NCI) C1306577) Death NOS;
Death/Expired;
Expired/death;
Patient Death;
Patient Expired =Finding |
- 535. DD96 Protein
- [Mostly expressed in kidney proximal tubular epithelial cells by human MAP17 Gene, 114-aa Membrane Associated Protein 17 kDa is an intracellular protein associated with the cytoplasmic aspect of the apical brush border plasma membrane that interacts with PDZK1. (NCI) ( NCI )] (UMLS (NCI) C0391485) =Amino Acid, Peptide, or Protein; Receptor ;
| - 585. death certificate
- [form signed by the attending physician indicating an individual's time and cause of death. ( CSP )] (UMLS (CSP) C0011066) =Manufactured Object ;
=health related legal;
|
- 536. ddA (dideoxyadenosine)
- [ ] (UMLS (CSP) C0045141) =Nucleic Acid, Nucleoside, or Nucleotide
| - 586. Death occurring in less than 24 hours from onset of symptoms, not otherwise explained
- (UMLS (ICD9CM) C0277590) =Pathologic Function
|
- 537. DDAVP
- (UMLS (NCI) C0701195) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 587. Death Rate
- (UMLS (NCI) C0205848) =Quantitative Concept ;
|
- 538. ddC/ZDV
- (UMLS (NCI) C0338082) =Therapeutic or Preventive Procedure
| - 588. death record
- [ ] (UMLS (CSP) C0011069) =Manufactured Object ;
|
- 539. DDD/DOX/VCR/VP-16
- (UMLS (NCI) C0281490) =Therapeutic or Preventive Procedure
| - 589. Death Valley Timbi-Sha Shoshone Band of California
- (UMLS (HL7) C1554291) =Population Group =NativeEntityContiguous;
|
- 540. DDEB (dominant dystrophic epidermolysis bullosa)
- [ ] (UMLS (CSP) C0079136) =Disease or Syndrome ;
| - 590. Death, Intrauterine Fetal
- [Death in utero; failure of the product of conception to show evidence of respiration, heart beat, or definite movement of a voluntary muscle after expulsion from the uterus, with no possibility of resuscitation. ( NCI )] (UMLS (NCI) C0015927) =Pathologic Function ;
=Dead;
Pregnancy Complication =Fetal Resorption;
|
- 541. ddG
- [ ] (UMLS (CSP) C0920460) dideoxyguanosine =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 591. DEBILITY NOS
- [ ] (UMLS (ICD9CM) C0347947) =Pathologic Function
|
- 542. ddG (dideoxyguanosine)
- [ ] (UMLS (CSP) C0080620) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 592. Debrazza monkey
- [ ] (UMLS (CSP) C0598111) =Mammal
|
- 543. DDMP
- [A diaminopyrimidine folate antagonist with potential antineoplastic activity. Metoprine inhibits dihydrofolate reductase, resulting in decreased cellular folate metabolism and cell growth; it also inhibits histamine-N-methyltransferase, resulting in decreased histamine catabolism. Lipid-soluble metoprine is capable of crossing the blood-brain barrier. (NCI04) ( NCI )] (UMLS (NCI) C0066142) =Organic Chemical; Pharmacologic Substance
| - 593. DEBRID OPEN FX-HUMERUS
- [ ] (UMLS (ICD9CM) C0186489) =Therapeutic or Preventive Procedure
|
- 544. ddNT
- [The phosphate esters of DIDEOXYNUCLEOSIDES. ( MSH )] (UMLS (CSP) C0599651) =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 594. DEBRID OPN FX-FEMUR
- [ ] (UMLS (ICD9CM) C0187862) =Therapeutic or Preventive Procedure
|
- 545. DDR1
- [This gene plays a role in extracellular matrix communication processes. ( NCI )] (UMLS (NCI) C1333206) DDR1 Gene;
Discoidin Domain Receptor Family, Member 1 Gene =Gene or Genome ;
| - 595. DEBRID OPN FX-FINGER
- [ ] (UMLS (ICD9CM) C0187303) =Therapeutic or Preventive Procedure
|
- 546. DDR2
- [Encoded by human DDR2 Gene (InRTK Subfamily) and expressed in heart, lung, brain, placenta, liver, skeletal muscle, pancreas, and kidney, 855-amino acid 96.8-kD precursor Discoidin Domain Receptor 2 is a receptor tyrosine kinase for fibrillar collagen involved in cell adhesion. Mediating fibroblast migration and proliferation, the type I membrane protein contains an intracellular catalytic domain and extracellular coagulation factor 5/8 type C and discoidin domains. RTKs often transduce signals by ligand induced receptor oligomerization, intracellular autophosphorylation, and phosphorylation of cytosolic targets. DDR2 may contribute to cutaneous wound healing. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0902406) DDR2 Protein;
Discoidin Domain Receptor 2;
Discoidin Domain Receptor Family Member 2;
Neurotrophic Tyrosine Kinase, Receptor-Related 3;
NTRKR3;
Receptor Protein-Tyrosine Kinase TKT;
TKT;
TYRO10;
Tyrosine Kinase Receptor Related to Neurotrophic TRK;
Tyrosine-Protein Kinase TYRO 10 =Amino Acid, Peptide, or Protein; Enzyme; Receptor | - 596. DEBRID OPN FX-METAC/CAR
- [ ] (UMLS (ICD9CM) C0177470) =Therapeutic or Preventive Procedure
|
- 547. DDR2
- [This gene plays a role in extracellular matrix communication processes and receptor-mediated signal transduction. ( NCI )] (UMLS (NCI) C1333207) DDR2 Gene;
Discoidin Domain Receptor Family, Member 2 Gene =Gene or Genome ;
| - 597. DEBRID OPN FX-METAT/TAR
- [ ] (UMLS (ICD9CM) C0188570) =Therapeutic or Preventive Procedure
|
- 548. DDS
- [systems for the delivery of drugs to target sites of pharmacological actions; technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. ( CSP )] (UMLS (NCI) C0085104) =Medical Device ;
=drug administration route;
=delayed action drug;
Dosage Form;
liposomal;
microcapsule;
prodrug;
Cutaneous Route of Administration;
Drug Vehicle | - 598. DEBRID OPN FX-RADIUS/ULN
- [ ] (UMLS (ICD9CM) C0186555) =Therapeutic or Preventive Procedure
|
- 549. DDT
- [ ] (UMLS (CSP) C0920453) dideoxythymidine =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 599. DEBRID OPN FX-TIBIA/FIB
- [ ] (UMLS (ICD9CM) C0187941) =Therapeutic or Preventive Procedure
|
- 550. ddT (dideoxythymidine)
- [ ] (UMLS (CSP) C0527161) =Nucleic Acid, Nucleoside, or Nucleotide ;
| - 600. DEBRID OPN FX-TOE
- [ ] (UMLS (ICD9CM) C0188571) =Therapeutic or Preventive Procedure
|
home
